A Method for Assessing Residual Biopotency of Antibiotics in Wastewater
A technology of bioefficacy and antibiotics, which is applied in the preparation of test samples, analysis by making materials react chemically, and material analysis by observing the influence on chemical indicators, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0089] Example 1 Standard Antibiotic Screening
[0090] 1. Preparation of standard bacterial solution
[0091] Take out the frozen Gram-positive bacteria Staphylococcus aureus (Staphyloccocusaureus) and Gram-negative bacteria Escherichia coli (Escherichiacoli) from the -80°C refrigerator, melt them in the refrigerator at 4°C, shake them well, and add them to antibiotic No. Ⅲ medium. Put them into a shaking incubator at 37° C. and shake them until the absorbance of the culture solution at a wavelength of 530 nm is between 0.3 and 0.7 to obtain revived Staphylococcus aureus and revived Escherichia coli respectively.
[0092] In the present invention, the resurrection culture temperature of Gram-positive bacteria and Gram-negative bacteria is 35-37°C, which is suitable for the present invention; the culture time is 4-5h.
[0093] After sterilizing the inoculation loop, dip in the revived Staphylococcus aureus standard bacteria solution and the revived Escherichia coli standard ...
Embodiment 2
[0144] The determination of embodiment 2 spiramycin production waste water residual comprehensive biological effectiveness
[0145] The embodiment of the present invention takes spiramycin production wastewater as an example to describe in detail, and the treatment process of spiramycin production wastewater is as follows figure 1 As shown, the spiramycin production wastewater passes through the regulating tank, the upflow anaerobic sludge bed (UASB, Up-flow Anaerobic Sludge Bed / Blanket), the anoxic tank, the aerobic tank, and the secondary sedimentation tank in sequence, and reaches the "fermentation pharmaceutical industry water Pollutant discharge standard GB21903-2008", direct discharge, of which: SPM-1 is the influent water before entering the regulating tank; SPM-2 is the anaerobic effluent after anaerobic sludge bed treatment; SPM-3 is the anoxic water SPM-4 is the effluent treated by the aerobic tank; SPM-5 is the effluent treated by the secondary sedimentation. Waste...
Embodiment 3-6
[0174] Example 3-6 Determination of comprehensive biological efficacy of spiramycin production wastewater residues
[0175] In addition to collecting wastewater water samples (SPM-2) from the effluent of the wastewater treatment workshop of the spiramycin production plant (SPM-2), anaerobic biological treatment from the wastewater treatment workshop of the spiramycin production plant Waste water samples (SPM-3) were collected from the effluent of the anoxic pool after the spiramycin production plant, wastewater samples (SPM-4) were collected from the effluent of the aerobic pool after aerobic biological treatment in the wastewater treatment workshop of the spiramycin production plant, and The wastewater sample (SPM-5) was collected from the outlet of the secondary sedimentation tank after the secondary biological treatment in the wastewater treatment workshop of the spiramycin production plant. The dilution factor of the wastewater sample (SPM-2) in Example 3 was 50 times. 200...
PUM
Property | Measurement | Unit |
---|---|---|
absorbance | aaaaa | aaaaa |
absorbance | aaaaa | aaaaa |
absorbance | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com